68ga-1,4,7-triazacyclononane-n,n',n''-triacetic acid
Small moleculeexperimentalImaging agent
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2014 (NCT02496013)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 68-gallium
Oral
No
Parenteral
No
Topical
No
Also known as
- 68ga-1,4,7-triazacyclononane-n,n',n''-triacetic acid
- 68ga-neb
- 68ga-neb
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04273334 | Phase 1 | Oct 1, 2019 | Chinese Academy of Medical Sciences |
| NCT02496013 | Phase 1 | Jan 1, 2014 | National Institutes of Health (NIH), Tsinghua University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2019 |
| National Institutes of Health (NIH) | Government | 1 | 0 | 1 | 2014 |
| Tsinghua University | Academic/Hospital | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1